<DOC>
	<DOC>NCT00979836</DOC>
	<brief_summary>The objective of the study is to assess the efficacy of calcium dobesilate for treating chronic venous wounds. The hypothesis is that venous ulcers treated with standards measures (compressive measures) and calcium dobesilate will heal-up better than venous ulcers treated with standards measures (compressive measures) and placebo.</brief_summary>
	<brief_title>Calcium Dobesilate for Chronic Venous Wounds</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Calcium, Dietary</mesh_term>
	<mesh_term>Calcium Dobesilate</mesh_term>
	<criteria>Patients with venous ulcer (CEAP 6) that affect epidermis, dermis and/or subcutaneous tissue, with and area superior to 3 cm2 Anklearm index 0.9 or superior Written informed consent of the patients Patients with venous ulcer (CEAP 6) that affect bone or with and area inferior to 3 cm2 Anklearm index inferior to 0.9 No written informed consent of the patients Diabetes mellitus I y II Patients with renal failure and dialysis Vascular surgery needed Impossibility to use compressive measures on the leg Use of topic antibiotics, silver dressing, growth factors, plasmarich in platelets, skin graft, pentoxifylline, ultrasounds, laser, hyperbaric oxygen, electric stimulation o vacuum. Pregnancy Breast feeding No anticonceptives measures Allergy or intolerance to phebotonics Background of neutropenia or leucopenia Basal leucocytes &lt; 3.500/ml</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>venous</keyword>
	<keyword>ulcer</keyword>
	<keyword>phlebotonic</keyword>
	<keyword>calcium dobesilate</keyword>
	<keyword>clinical trial</keyword>
</DOC>